Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients
Ovarian Tissue Cryopreservation will be provided to cancer patients to allow them to have their fertility preserved.
Trial Details
- NCT ID
- NCT05830929
- Phase
- NA
- Sponsor
- Chinese University of Hong Kong
- Status
- RECRUITING
- Cancer Type
- Ovarian Cancer
- Interventions
- Ovarian tissue freezing and subsequent auto-transplantation after thawing
- Locations (sample)
- Hong Kong, Hong Kong|22.27832,114.17469
Key Eligibility Criteria
- Patients aged from 0-35 years old and diagnosed with cancer e.g., leukaemia, myeloproliferative or myelodysplastic diseases, lymphoma, bone tumours…
- Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdomi…
- Patients suffering from hormone-sensitive malignancies who will undergo medical treatment, such as radiotherapy and chemotherapy that is liable to …
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Ovarian Cancer Trials on Trialify →